ReviewVeterinary sciences2026
Considerations About the Antimicrobial Activity of Oxidized Cellulose and Oxidized Regenerated Cellulose and Their Potential Application in Veterinary Surgery.
Review in Veterinary sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preclinical Performance Evaluation of an Oxidized Regenerated Cellulose Hemostat: Antibacterial Activity and Wound Healing Outcomes.Medical devices (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidized cellulose (OC) and oxidized regenerated cellulose (ORC) are bioabsorbable polysaccharide-based materials widely used in surgery for topical hemostasis. Beyond their established hemostatic role, increasing attention has been directed toward their potential antimicrobial activity, primarily attributed to local acidification following carboxyl group dissociation. Discussing the possible implications of the antibacterial properties of OC/ORC in veterinary surgical practice, this review critically examines the existing evidence. In vitro studies show that viable bacterial counts are significantly reduced in both Gram-positive and Gram-negative pathogens, including antibiotic-resistant strains. Historical in vivo animal models further support a reduction in bacterial recovery in contaminated tissues treated with OC. However, contemporary veterinary clinical trials specifically evaluating surgical site infection (SSI) outcomes remain limited. Documented limitations include variability in formulation, quantity-dependent degradation kinetics, and the potential for foreign body reactions when excessive material is retained. Current evidence suggests that OC may provide adjunctive antimicrobial effects under controlled experimental conditions, primarily in vitro and in standardized animal models, but these properties should be interpreted with caution, and its role should be integrated within comprehensive infection prevention strategies rather than considered a substitute for established perioperative protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.